Kloska, A, Malinowska, M, Gabig-Ciminska, M, Jakobkiewicz-Banecka, J
Mazza waived concerns that investors have missed out on the rally, noting the weight loss drug industry is still in its "early days." "The marketplace has plenty of room for growth with other companies coming in, whether they're with more powerful drugs or with things that actually you don't need to have an injectable." He also sees GLP-1 drugmakers following a similar trajectory to AI-linked stocks
Never adjust your Ozempic dose or stop taking it without consulting your healthcare provider, as this may lead to deterioration in glucose control
Experts have also raised concerns about the safety of the ingredients themselves
Valuables Please DO NOT bring any valuables on the day of the procedure such as jewelleries